Monitor first-day trading for signs of demand and near-term catalysts: Phase 2b BUOY-1 topline data for GlyphAllo expected in H1 2027, and Phase 2a/2b data for GlyphAgo in 2028. The strong IPO pricing and upsizing signal positive sentiment, but the stock may experience volatility as lock-ups expire and clinical milestones approach.
Executive Summary
Seaport Therapeutics completed its initial public offering of 14,160,000 shares at $18.00 per share, raising $254.9 million in gross proceeds ($233.9 million net). The offering was upsized from the original $100 million target and priced at the top of the $16-$18 range, indicating strong investor demand. The company will use the proceeds to advance its pipeline of neuropsychiatric drugs, including GlyphAllo (Phase 2b) and GlyphAgo (Phase 1/2).
Key Financial Metrics
Key Facts
- IPO of 14,160,000 shares priced at $18.00 per share, raising $254.9 million gross
- Underwriters granted 30-day option to purchase up to 2,124,000 additional shares
- Net proceeds to company approximately $233.9 million ($269.5 million if greenshoe exercised)
- Stock to trade on Nasdaq Global Select Market under symbol SPTX
- Use of proceeds: ~$176M for GlyphAllo Phase 2b/3, ~$104M for GlyphAgo Phase 2a/2b, remainder for Glyph2BLSD and general corporate purposes
- Prior S-1/A indicated strong investor interest including $50M indication from General Atlantic
Financial Impact
IPO proceeds of $254.9 million gross ($233.9 million net) will fund operations into 2029
Risk Factors
- Clinical-stage biotech with no approved products or revenue; high dependency on clinical trial outcomes
- Significant operating losses and need for future capital raises
- Potential for adverse clinical data or regulatory setbacks for lead candidates
- Lock-up expiration after 180 days may pressure stock price
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B4 Filing (Primary) | 0001193125-26-201758 |
| Document: 0001193125-26-201758-index-headers.html | 0001193125-26-201758 |
| Document: 0001193125-26-201758-index.html | 0001193125-26-201758 |
| Document: 0001193125-26-201758.txt | 0001193125-26-201758 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 3, 2026 12w ago | 8-K | $20.65 | awaiting T+60 | — | $21.42 (+3.73%) |
Jun 8, 2026 20w ago | 8-K | $16.20 $23.61 | ▲ +45.74% | ▲ +42.69% | $21.42 (+32.22%) |
May 6, 2026 24w ago | 3 | $15.50 $20.65 | ▲ +33.23% | ▲ +29.39% | $21.42 (+38.19%) |
May 1, 2026 25w ago | 424B4 | $17.00 $19.74 | ▲ +16.12% | ▲ +14.26% | $21.42 (+26.00%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $21.42 (+7.96%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $21.42 (+7.96%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $21.42 (+7.96%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $21.42 (+7.96%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $21.42 (+7.96%) |
Apr 27, 2026 26w ago | S-1/A | — | awaiting T+60 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers